Ozempic is adding a new layer of pressure on how relatives talk about weight and bodies, with linked stories on how families are dealing with it.
Recap by typeshit. Post by Facebook on Facebook.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
Drugs.com
Eligibility usually starts at a BMI of 30, or 27 with a weight-related condition. The piece also covers costs, side effects and why most people stay on these drugs long term.
Good Morning America looks at GLP-1 use spreading from adults to a growing number of teens being treated for obesity.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
A short clip aimed at new mothers thinking about restarting GLP-1s like Ozempic or Wegovy while nursing, with a caution to hear first.
A short clip aimed at breastfeeding mothers thinking about going back on GLP-1s. The hosts say there is something to know first, without giving details here.
Loading…